日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs

一项随机III期临床试验,研究吡罗昔康联合米托蒽醌或卡铂一线治疗犬泌尿生殖道移行细胞癌的疗效。

Allstadt, S D; Rodriguez, C O Jr; Boostrom, B; Rebhun, R B; Skorupski, K A

Bacterial urinary tract infections associated with transitional cell carcinoma in dogs

犬类移行细胞癌相关的细菌性尿路感染

Budreckis, D M; Byrne, B A; Pollard, R E; Rebhun, R B; Rodriguez, C O Jr; Skorupski, K A

Clinical characteristics and outcome in dogs with splenic marginal zone lymphoma

犬脾边缘区淋巴瘤的临床特征和预后

O'Brien, D; Moore, P F; Vernau, W; Peauroi, J R; Rebhun, R B; Rodriguez, C O Jr; Skorupski, K A

Circulating immune complexes containing secretory IgA in jejunoileal bypass disease

空回肠旁路疾病中含有分泌型IgA的循环免疫复合物

Clegg, D O; Zone, J J; Samuelson, C O Jr; Ward, J R